Immunological Disorders and Immunotherapy
Open Access

Clinical Implications of Immunosuppressive Drug-related Adverse Events

Aran Jonas^{* *}Correspondence: Aran Jonas, Department of Immunology, Stony Brook University, New York, USA, Email:

Author info »

Description

Immunosuppressive drugs play a crucial role in managing various medical conditions, especially those related to autoimmune disorders and organ transplantation. These medications work by suppressing the immune system's activity, which can be beneficial in preventing the body from attacking its own tissues or rejecting transplanted organs. However, like any medication, immunosuppressive drugs come with their set of side effects that need to be carefully considered and monitored.

Types of immunosuppressive drugs

There are several types of immunosuppressive drugs, each with its unique mechanism of action. Commonly prescribed immunosuppressants include corticosteroids, calcineurin inhibitors, antimetabolites, and biological agents.

Corticosteroids: These drugs, such as prednisone and methylprednisolone, are potent anti-inflammatory agents [1]. They work by suppressing the immune response and reducing inflammation. While effective, long-term use of corticosteroids can lead to side effects such as weight gain, osteoporosis, and an increased risk of infections.

Calcineurin inhibitors: Medications like cyclosporine and tacrolimus inhibit the activity of calcineurin, a protein involved in immune system regulation [2]. Side effects may include kidney problems, high blood pressure, and an increased risk of certain infections.

Antimetabolites: Drugs like azathioprine and mycophenolate mofetil interfere with DNA synthesis in rapidly dividing cells, including immune cells [3]. Side effects may include gastrointestinal issues, liver problems, and an increased susceptibility to infections.

Biological agents: These drugs, such as infliximab and adalimumab, target specific components of the immune system. They are commonly used in autoimmune diseases like rheumatoid arthritis and inflammatory bowel disease. Side effects may include infusion reactions, increased risk of infections, and potential long-term effects still under investigation [4].

Side effects of immunosuppressive drugs

Increased risk of infections: One of the primary concerns with immunosuppressive drugs is the heightened susceptibility to infections. Since these medications compromise the immune system's ability to fight off pathogens, individuals taking them may experience more frequent and severe infections [5]. It is essential for patients and healthcare providers to be vigilant in monitoring for signs of infection.

Kidney problems: Some immunosuppressive drugs, especially calcineurin inhibitors, can affect kidney function. Regular monitoring of kidney function through blood tests is crucial to detect any potential issues early on.

Gastrointestinal issues: Antimetabolites, such as azathioprine, may cause gastrointestinal side effects like nausea, vomiting, and diarrhea [6]. These symptoms can be challenging for patients and may affect their overall quality of life.

Cardiovascular complications: Certain immunosuppressive drugs, particularly corticosteroids, can contribute to conditions such as high blood pressure and an increased risk of cardiovascular diseases [7]. Monitoring cardiovascular health is crucial for patients on long-term immunosuppressive therapy.

Metabolic changes: Corticosteroids may lead to metabolic changes, including weight gain, increased blood sugar levels, and changes in lipid profiles [8]. These changes can contribute to conditions like diabetes and hyperlipidemia.

Immunosuppressive drugs are invaluable in the management of autoimmune disorders and post-organ transplant care [9]. While they provide essential benefits, it is crucial to recognize and manage their potential side effects. Regular monitoring, communication between patients and healthcare providers, and adjustments to medication regimens when necessary can help mitigate the risks associated with these medications [10].

Striking a balance between suppressing the immune system to achieve therapeutic goals and minimizing side effects is a delicate but essential aspect of patient care in immunosuppressive therapy.

References

1. Liu J, Qi C, Tao K, Zhang J, Zhang J, Xu L, et al. Sericin/dextran injectable hydrogel as an optically trackable drug delivery system for malignant melanoma treatment. ACS Appl Mater Interfaces. 2016;8(10):6411-6422.
2. Restifo NP, Gattinoni L. Lineage relationship of effector and memory T cells. Curr Opin Immunol. 2013;25(5):556-563.
3. Vijay K. Toll-like receptors in immunity and inflammatory diseases: Past, present, and future. Int Immunopharmacol. 2018;59:391-412. 
4. Holtmeier W, Kabelitz D. γδ T cells link innate and adaptive immune responses. Chem Immunol Allergy. 2005;86:151-183.
5. Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol.2011;30(1):16-34.
6. Ghazal S, Kumar A, Shrestha B, Sajid S, Malik M, Rizvi N. Risk factors predicting mortality in patients with lung abscess in a public tertiary care center in Karachi, Pakistan. JNMA J Nepal Med Assis. 2013;52:571-575.
7. Monteiro R, Alfaro TM, Correia L, Simoa A, Carvalho A, Costa JN. Lung abscess and thoracic empyema: Retrospective analysis in an internal medicine department. Acta Med Port. 2011;24:229-240.
8. Schweigert M, Dubecz A, Stadlhuber RJ, Stein HJ. Modern history of surgical management of lung abscess: From Harold Neuhof to current concepts. Ann Thorac Surg. 2011;92:2293-2297.
9. Kroenke K, Karlie M, Karaj G, Peradzynska J, Krauze A, Kulus M. Risk factors for local complications in children with community-acquired pneumonia. Clin Respir J. 2018;12:253-261.
10. Monteiro R, Alfaro TM, Correia L, Simoa A, Carvalho A, Costa JN. Lung abscess and thoracic empyema: Retrospective analysis in an internal medicine department. Acta Med Port. 2011;24:229-240.